Hyaluronic Acid is Associated with Severity and Prognosis in Patients with Community-Acquired Pneumonia

Yingying Lin,1,* Yanyan Li,2,* Xinyu Cui,2 Na Zhu,2 Xin Li1 1Department of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital, Beijing, People’s Republic of China; 2Department of Center of Integrated Traditional Chinese and Wester...

Full description

Saved in:
Bibliographic Details
Main Authors: Lin Y, Li Y, Cui X, Zhu N, Li X
Format: Article
Language:English
Published: Dove Medical Press 2024-12-01
Series:Journal of Inflammation Research
Subjects:
Online Access:https://www.dovepress.com/hyaluronic-acid-is-associated-with-severity-and-prognosis-in-patients--peer-reviewed-fulltext-article-JIR
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846093600499171328
author Lin Y
Li Y
Cui X
Zhu N
Li X
author_facet Lin Y
Li Y
Cui X
Zhu N
Li X
author_sort Lin Y
collection DOAJ
description Yingying Lin,1,&ast; Yanyan Li,2,&ast; Xinyu Cui,2 Na Zhu,2 Xin Li1 1Department of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital, Beijing, People’s Republic of China; 2Department of Center of Integrated Traditional Chinese and Western Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Xin Li, Department of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital, No. 8, Jingshun East Street, Chaoyang District, Beijing, 100015, People’s Republic of China, Tel +86 13910908996, Email leaxin@ccmu.edu.cnPurpose: Hyaluronic acid (HA) is a novel inflammatory biomarker with a prognostic value for several infectious diseases. This study investigated the association of HA with severity and prognosis in hospitalized patients with community-acquired pneumonia (CAP).Patients and Methods: We analyzed the differences of HA levels in different groups. Logistic regression analysis was performed to identify independent risk factors for severe CAP (SCAP). The predictive value of HA for SCAP was assessed using receiver operating characteristic (ROC) curves. Kaplan-Meier survival analysis was used to compare 30-day mortality between the high and low HA groups.Results: Compared to healthy controls (49.2 ± 15.3 ng/mL), patients with CAP exhibited significantly elevated levels of HA (P < 0.001). In CAP patients, increased HA levels were more pronounced in those with SCAP (SCAP vs non-SCAP:135.6 ± 51 ng/mL vs 100.7 ± 47.8 ng/mL, P < 0.001). Compared to survivors (109.9 ± 48.7 ng/mL), HA levels in non-survivors were significantly higher (180.9 ± 67.8 ng/mL) (P < 0.001). HA was an independent predictor of SCAP [odds ratio (OR): 1.013, 95% confidence interval (CI): 1.003– 1.022, P = 0.011] with high diagnostic accuracy [areas under the curve (AUC): 0.709, 95% CI: 0.622– 0.797, P = 0.001]. Additionally, HA was independently associated with death risk in patients with CAP (OR: 1.022, 95% CI: 1.005– 1.039, P = 0.010). Kaplan-Meier survival curves indicated that CAP patients in the high HA group exhibit a higher 30-day mortality rate compared to those in the low HA group (8.6% vs 1.5%, P = 0.008). Post hoc analysis indicated that our study possessed 98.857% statistical power.Conclusion: In conclusion, High HA levels are associated with severity and mortality in patients with CAP, and HA could serve as a novel serum biomarker to predict the risk of CAP progression.Keywords: hyaluronic acid, community-acquired pneumonia, severity, prognosis, biomarker
format Article
id doaj-art-bf1e110fb2d44e1eb051797f2505c86c
institution Kabale University
issn 1178-7031
language English
publishDate 2024-12-01
publisher Dove Medical Press
record_format Article
series Journal of Inflammation Research
spelling doaj-art-bf1e110fb2d44e1eb051797f2505c86c2025-01-02T17:00:44ZengDove Medical PressJournal of Inflammation Research1178-70312024-12-01Volume 17118811189598847Hyaluronic Acid is Associated with Severity and Prognosis in Patients with Community-Acquired PneumoniaLin YLi YCui XZhu NLi XYingying Lin,1,&ast; Yanyan Li,2,&ast; Xinyu Cui,2 Na Zhu,2 Xin Li1 1Department of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital, Beijing, People’s Republic of China; 2Department of Center of Integrated Traditional Chinese and Western Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Xin Li, Department of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital, No. 8, Jingshun East Street, Chaoyang District, Beijing, 100015, People’s Republic of China, Tel +86 13910908996, Email leaxin@ccmu.edu.cnPurpose: Hyaluronic acid (HA) is a novel inflammatory biomarker with a prognostic value for several infectious diseases. This study investigated the association of HA with severity and prognosis in hospitalized patients with community-acquired pneumonia (CAP).Patients and Methods: We analyzed the differences of HA levels in different groups. Logistic regression analysis was performed to identify independent risk factors for severe CAP (SCAP). The predictive value of HA for SCAP was assessed using receiver operating characteristic (ROC) curves. Kaplan-Meier survival analysis was used to compare 30-day mortality between the high and low HA groups.Results: Compared to healthy controls (49.2 ± 15.3 ng/mL), patients with CAP exhibited significantly elevated levels of HA (P < 0.001). In CAP patients, increased HA levels were more pronounced in those with SCAP (SCAP vs non-SCAP:135.6 ± 51 ng/mL vs 100.7 ± 47.8 ng/mL, P < 0.001). Compared to survivors (109.9 ± 48.7 ng/mL), HA levels in non-survivors were significantly higher (180.9 ± 67.8 ng/mL) (P < 0.001). HA was an independent predictor of SCAP [odds ratio (OR): 1.013, 95% confidence interval (CI): 1.003– 1.022, P = 0.011] with high diagnostic accuracy [areas under the curve (AUC): 0.709, 95% CI: 0.622– 0.797, P = 0.001]. Additionally, HA was independently associated with death risk in patients with CAP (OR: 1.022, 95% CI: 1.005– 1.039, P = 0.010). Kaplan-Meier survival curves indicated that CAP patients in the high HA group exhibit a higher 30-day mortality rate compared to those in the low HA group (8.6% vs 1.5%, P = 0.008). Post hoc analysis indicated that our study possessed 98.857% statistical power.Conclusion: In conclusion, High HA levels are associated with severity and mortality in patients with CAP, and HA could serve as a novel serum biomarker to predict the risk of CAP progression.Keywords: hyaluronic acid, community-acquired pneumonia, severity, prognosis, biomarkerhttps://www.dovepress.com/hyaluronic-acid-is-associated-with-severity-and-prognosis-in-patients--peer-reviewed-fulltext-article-JIRhyaluronic acidcommunity-acquired pneumoniaseverityprognosisbiomarker
spellingShingle Lin Y
Li Y
Cui X
Zhu N
Li X
Hyaluronic Acid is Associated with Severity and Prognosis in Patients with Community-Acquired Pneumonia
Journal of Inflammation Research
hyaluronic acid
community-acquired pneumonia
severity
prognosis
biomarker
title Hyaluronic Acid is Associated with Severity and Prognosis in Patients with Community-Acquired Pneumonia
title_full Hyaluronic Acid is Associated with Severity and Prognosis in Patients with Community-Acquired Pneumonia
title_fullStr Hyaluronic Acid is Associated with Severity and Prognosis in Patients with Community-Acquired Pneumonia
title_full_unstemmed Hyaluronic Acid is Associated with Severity and Prognosis in Patients with Community-Acquired Pneumonia
title_short Hyaluronic Acid is Associated with Severity and Prognosis in Patients with Community-Acquired Pneumonia
title_sort hyaluronic acid is associated with severity and prognosis in patients with community acquired pneumonia
topic hyaluronic acid
community-acquired pneumonia
severity
prognosis
biomarker
url https://www.dovepress.com/hyaluronic-acid-is-associated-with-severity-and-prognosis-in-patients--peer-reviewed-fulltext-article-JIR
work_keys_str_mv AT liny hyaluronicacidisassociatedwithseverityandprognosisinpatientswithcommunityacquiredpneumonia
AT liy hyaluronicacidisassociatedwithseverityandprognosisinpatientswithcommunityacquiredpneumonia
AT cuix hyaluronicacidisassociatedwithseverityandprognosisinpatientswithcommunityacquiredpneumonia
AT zhun hyaluronicacidisassociatedwithseverityandprognosisinpatientswithcommunityacquiredpneumonia
AT lix hyaluronicacidisassociatedwithseverityandprognosisinpatientswithcommunityacquiredpneumonia